Relevance of BET Family Proteins in SARS-CoV-2 Infection

The recent pandemic we are experiencing caused by the coronavirus disease 2019 (COVID-19) has put the world’s population on the rack, with more than 191 million cases and more than 4.1 million deaths confirmed to date. This disease is caused by a new type of coronavirus, the severe acute respiratory...

Full description

Bibliographic Details
Main Authors: Nieves Lara-Ureña, Mario García-Domínguez
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/11/8/1126
_version_ 1827685814072508416
author Nieves Lara-Ureña
Mario García-Domínguez
author_facet Nieves Lara-Ureña
Mario García-Domínguez
author_sort Nieves Lara-Ureña
collection DOAJ
description The recent pandemic we are experiencing caused by the coronavirus disease 2019 (COVID-19) has put the world’s population on the rack, with more than 191 million cases and more than 4.1 million deaths confirmed to date. This disease is caused by a new type of coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A massive proteomic analysis has revealed that one of the structural proteins of the virus, the E protein, interacts with BRD2 and BRD4 proteins of the Bromodomain and Extra Terminal domain (BET) family of proteins. BETs are essential to cell cycle progression, inflammation and immune response and have also been strongly associated with infection by different types of viruses. The fundamental role BET proteins play in transcription makes them appropriate targets for the propagation strategies of some viruses. Recognition of histone acetylation by BET bromodomains is essential for transcription control. The development of drugs mimicking acetyl groups, and thereby able to displace BET proteins from chromatin, has boosted interest on BETs as attractive targets for therapeutic intervention. The success of these drugs against a variety of diseases in cellular and animal models has been recently enlarged with promising results from SARS-CoV-2 infection studies.
first_indexed 2024-03-10T08:59:46Z
format Article
id doaj.art-ca352750332f4a369d101b0e68aa3612
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T08:59:46Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-ca352750332f4a369d101b0e68aa36122023-11-22T06:55:12ZengMDPI AGBiomolecules2218-273X2021-07-01118112610.3390/biom11081126Relevance of BET Family Proteins in SARS-CoV-2 InfectionNieves Lara-Ureña0Mario García-Domínguez1Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER), CSIC-Universidad de Sevilla-Universidad Pablo de Olavide, Av. Américo Vespucio 24, 41092 Seville, SpainAndalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER), CSIC-Universidad de Sevilla-Universidad Pablo de Olavide, Av. Américo Vespucio 24, 41092 Seville, SpainThe recent pandemic we are experiencing caused by the coronavirus disease 2019 (COVID-19) has put the world’s population on the rack, with more than 191 million cases and more than 4.1 million deaths confirmed to date. This disease is caused by a new type of coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A massive proteomic analysis has revealed that one of the structural proteins of the virus, the E protein, interacts with BRD2 and BRD4 proteins of the Bromodomain and Extra Terminal domain (BET) family of proteins. BETs are essential to cell cycle progression, inflammation and immune response and have also been strongly associated with infection by different types of viruses. The fundamental role BET proteins play in transcription makes them appropriate targets for the propagation strategies of some viruses. Recognition of histone acetylation by BET bromodomains is essential for transcription control. The development of drugs mimicking acetyl groups, and thereby able to displace BET proteins from chromatin, has boosted interest on BETs as attractive targets for therapeutic intervention. The success of these drugs against a variety of diseases in cellular and animal models has been recently enlarged with promising results from SARS-CoV-2 infection studies.https://www.mdpi.com/2218-273X/11/8/1126SARS-CoV-2COVID-19BETBET inhibitorsBRD4BRD2
spellingShingle Nieves Lara-Ureña
Mario García-Domínguez
Relevance of BET Family Proteins in SARS-CoV-2 Infection
Biomolecules
SARS-CoV-2
COVID-19
BET
BET inhibitors
BRD4
BRD2
title Relevance of BET Family Proteins in SARS-CoV-2 Infection
title_full Relevance of BET Family Proteins in SARS-CoV-2 Infection
title_fullStr Relevance of BET Family Proteins in SARS-CoV-2 Infection
title_full_unstemmed Relevance of BET Family Proteins in SARS-CoV-2 Infection
title_short Relevance of BET Family Proteins in SARS-CoV-2 Infection
title_sort relevance of bet family proteins in sars cov 2 infection
topic SARS-CoV-2
COVID-19
BET
BET inhibitors
BRD4
BRD2
url https://www.mdpi.com/2218-273X/11/8/1126
work_keys_str_mv AT nieveslaraurena relevanceofbetfamilyproteinsinsarscov2infection
AT mariogarciadominguez relevanceofbetfamilyproteinsinsarscov2infection